You are here
TGA Internet site archive
The content on this page and other TGA archive pages is provided to assist research and may contain references to activities or policies that have no current application. See the full archive disclaimer.
Manufacturing notices (archived)
2017
- PIC/S & EMA consultation
20 December 2017: PIC/S in partnership with the EMA and WHO releases draft of Annex 1 to the "Guide to GMP for Medicinal Products" for public consultation - Transition to new GMP requirements for medicinal products
21 November 2017: A notice about the implications of adopting PE009-13 - Questions & answers on the code of good manufacturing practice for medicinal products
29 September 2017: Q&A about the PIC/S Guide to Good Manufacturing Practice - 15 January 2009, PE 009-8 - Updated GMP Clearance application forms
26 September 2017: GMP Clearance application forms now available - TGA updates GMP Clearance Guidance
19 September 2017: Updated guidance on GMP Clearance processes & new GMP Clearance Application Assistance Tool (CAAT) - Update to manufacturing principles for medicines, APIs and sunscreens
13 September 2017: Notification of intent to adopt the current PIC/S Guide to GMP, PE009-13 as Manufacturing Principles - GMP clearance process - compliance verification
11 September 2017: Australian sponsors of medicines manufactured overseas have a responsibility to ensure that all required documents are submitted with a GMP Clearance application - Reminder: Planned process improvements for GMP Clearance
8 September 2017: Reminder about planned process improvements for GMP Clearance in September - Planned process improvements for GMP Clearance
15 August 2017: TGA are planning process improvements for GMP Clearance in September 2017 - Electronic signatures to replace 'wet ink' signatures
5 July 2017: All Licences and Certificates of GMP Compliance issued by the TGA will be signed "electronically" and no longer contain a wet ink signature - GMP clearance process - Fees for compliance verification GMP clearance applications
21 June 2017: Update regarding GMP clearance Compliance Verification (CV) fees - Target processing timeline for MRA GMP clearance applications
24 April 2017: Update on target processing timeline for MRA GMP clearance applications - Withdrawal of "under review" GMP clearance applications that are no longer required
5 April 2017: Update on compliance verification GMP clearance applications - Withdrawal of "under review" GMP clearance applications that are no longer required - Update on compliance verification GMP clearance applications
5 January 2017: Common issues with compliance verification GMP clearance applications
2016
- Online payment of licence application fees by biological manufacturers
20 October 2016: We have identified a billing issue in our online systems - Revised risk management strategy for manufacturers of medicines and blood, tissues and cellular therapies
30 September 2016: Update to the manufacturer risk management framework and reinspection frequencies for medicines, blood, tissues and cellular therapies - MRA GMP clearance application processing timelines
6 May 2016: The TGA is working on improving our ability to meet demand by reforming our processes - The TGA updates processes for the close-out of on-site GMP inspections
12 May 2016: The process for conducting post-inspection activities have been reviewed to allow a more efficient resolution of deficiencies and close-out of inspections and to align with international practice
2015
- Issues affecting documentation attached to some GMP clearance applications
30 July 2015: The TGA has become aware of issues affecting documentation attached to some GMP clearance applications
2013
- Revised code of GMP for human blood and tissues
4 June 2013: The Australian Code of Good Manufacturing Practice for human blood and blood components, human tissues and human cellular therapy products 2013 commences on 31 May 2013 - Manufacturer audits are now termed inspections
29 April 2013: The TGA is changing its terminology - the word 'inspection' is replacing the word 'audit'.
2012
- Medical device amendments to the EU-Australia MRA on conformity assessment to come into effect 1 January 2013
30 November 2012: Amendments to the EU-Australia MRA (Mutual Recognition Agreements) on conformity assessment to come into force on 1 January 2013
2011
- New format for TGA conformity assessment certificates
13 October 2011: The new format and design of the conformity assessment certificates incorporate features and improvements